E-Cadherin-Deficient Cells Are Sensitive to the Multikinase Inhibitor Dasatinib.

Bougen-Zhukov N, Decourtye-Espiard L, Mitchell W, Redpath K, Perkinson J, Godwin T, Black MA, Guilford P

Open source

DOI
10.3390/cancers14071609
Published
2022 Mar 22
Container
Cancers
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers14071609,
  title = {E-Cadherin-Deficient Cells Are Sensitive to the Multikinase Inhibitor Dasatinib.},
  author = {Bougen-Zhukov N and Decourtye-Espiard L and Mitchell W and Redpath K and Perkinson J and Godwin T and Black MA and Guilford P},
  year = {2022},
  journal = {Cancers},
  doi = {10.3390/cancers14071609},
  url = {https://doi.org/10.3390/cancers14071609}
}

RIS

TY  - JOUR
TI  - E-Cadherin-Deficient Cells Are Sensitive to the Multikinase Inhibitor Dasatinib.
AU  - Bougen-Zhukov N
AU  - Decourtye-Espiard L
AU  - Mitchell W
AU  - Redpath K
AU  - Perkinson J
AU  - Godwin T
AU  - Black MA
AU  - Guilford P
PY  - 2022
JO  - Cancers
DO  - 10.3390/cancers14071609
UR  - https://doi.org/10.3390/cancers14071609
ER  - 

APA

N, B., L, D., W, M., K, R., J, P., T, G., MA, B., & P, G. (2022). E-Cadherin-Deficient Cells Are Sensitive to the Multikinase Inhibitor Dasatinib.. Cancers. https://doi.org/10.3390/cancers14071609

Source records